期刊文献+

miR-145靶向调控DAB2对前列腺癌PC3细胞迁移和侵袭能力的影响 被引量:3

Effects of miR-145 on the migration and invasion of prostate cancer PC3 cells by targeting DAB2
下载PDF
导出
摘要 已有研究表明,miR-145在多种肿瘤中低表达,并与细胞增殖和转移相关。文章通过生物信息学分析并结合体外实验鉴定,发现DAB2(Disabled homolog 2)为miR-145在肿瘤转移过程中累及的新靶点。DAB2一直被认为是一个重要的抑癌基因,在多种肿瘤标本中表达低下。然而,研究发现,在具高侵袭能力的前列腺癌细胞株PC3中DAB2基因却呈较高水平表达。另外,外源表达miR-145能显著下调DAB2表达水平,并抑制PC3细胞的迁移和侵袭能力,且这种miR-145诱导的PC3细胞功能缺陷能被DAB2过表达修复。上述结果表明,miR-145能通过靶向调控DAB2而影响高侵袭前列腺癌细胞的迁移和侵袭能力。 It was reported that miR-145, which is significantly decreased in a variety of tumor cells, is associated with cell proliferation and metastasis. In this study, using bioinformaties analysis and in vitro assays, we identified DAB2 (Disa bled homolog 2) as a downstream target gene ofmiR-145 during tumor metastasis process. DAB2 has been characterized as an important tumor suppressor, and is usually expressed at low levels in tumor cells. However, in this study, the relative high-level expression of DAB2 gene was observed in the highly invasive prostate cancer PC3 cells. Moreover, enforced expression of miR-145 could significantly down-regulate the expression level of DAB2 in PC3 cells, and inhibit the migra- tion and invasion of PC3 cells. Notably, dysfunction of PC3 cells induced by miR-145 overexpression can be rescued by co-overexpression of DAB2. These results demonstrate that miR-145 regulates the migration and invasion of highly invasiveprostate cancer cells through targeting DAB2 gene.
出处 《遗传》 CAS CSCD 北大核心 2014年第1期50-57,共8页 Hereditas(Beijing)
基金 教育部"新世纪优秀人才支持计划"(编号:NCET-09-0541)资助
关键词 MIR-145 DAB2基因 前列腺癌细胞PC3 细胞迁移和侵袭 miR-145 DAB2 prostate cancer cell PC3 cell migration and invasion
  • 相关文献

参考文献19

  • 1Porkka KP,Pfeiffer MJ,Waltering KK,Vessella RL Tammela TL Visakorpi T. MicroRNA expression profiling in prostate cancer[J].{H}CANCER RESEARCH,2007,(13):6130-6135.
  • 2Ozen M,Creighton CJ,Ozdemir M,Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer[J].{H}ONCOGENE,2008,(12):1788-1793.
  • 3Michael MZ,SM OC,Van Holst Pellekaan NG,Young GP James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia[J].{H}Molecular Cancer Research,2003,(12):882-891.
  • 4Takagi T,Iio A,Nakagawa Y,Naoe T Tanigawa N Akao Y. Decreased expression of microRNA-143 and -145 in human gastric cancers[J].{H}ONCOLOGY-BASEL,2009,(01):12-21.
  • 5Akao Y,Nakagawa Y,Naoe T. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers[J].{H}Oncology Reports,2006,(04):845-850.
  • 6Kano M,Seki N,Kikkawa N,Fujimura L Hoshino I Akutsu Y Chiyomaru T Enokida H Nakagawa M Matsubara H. miR-145,miR-133a and miR-133b:Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma[J].{H}International Journal of Cancer,2010,(12):2804-2814.
  • 7Bandrés E,Cubedo E,Agirre X,Malumbres R Zárate R Ramirez N Abajo A Navarro A Morenó I Monzo M García-Foncillas J. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues[J].{H}Molecular Cancer Therapautics,2006.29.
  • 8Chiyomaru T,Tatarano S,Kawakami K,Enokida H Yoshino H Nohata N Fuse M Seki N Nakagawa M. SWAP70,actin-binding protein,function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer[J].{H}PROSTATE,2011,(14).
  • 9Chen H,Toyooka S,Gazdar AF,Hsieh JT. Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines[J].{H}Journal of Biological Chemistry,2003,(05):3121-3130.
  • 10Dote H,Toyooka S,Tsukuda K,Yano M Ouchida M Doihara H Suzuki M Chen H Hsieh JT Gazdar AF Shimizu N. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer[J].{H}Clinical Cancer Research,2004,(06):2082-2089.

同被引文献52

  • 1姜熙,曹志刚,戚敏俊,许旭,赵树立.南京地区汉族人群VDR基因多态性与前列腺癌易感性的关系研究[J].中华男科学杂志,2013,19(10):953-955. 被引量:5
  • 2Formosa A,Lena AM,Markert EK,et al.DNA methylation silences miR-132 in prostate cancer.Oncogene,2013,32(1):127-134.
  • 3Selth LA,Townley SL,Bert AG,et al.Circulating microRNAs predict biochemical recurrence in prostate cancer patients.Br J Cancer,2013,109(3):641-650.
  • 4Moltzahn F,Olshen AB,Baehner L,et al.Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic micro RNA signatures in the sera of prostate cancer patients.Cancer Res,2011,71(2):550-560.
  • 5Sita-Lumsden A,Dart DA,Waxman J,et al.Circulating microRNAs as potential new biomarkers for prostate cancer.Br J Cancer,2013,108(10):1925-1930.
  • 6Kneitz B,Krebs M,Kalogirou C,et al.Survival in patients with high-risk prostate cancer is predicted by miR-221,which regulates proliferation,apoptosis,and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3.Cancer Res,2014,74(9):2591-2603.
  • 7Shen J,Hruby GW,Mc Kiernan JM,et al.Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer.Prostate,2012,72(13):1469-1477.
  • 8Amir S,Ma AH,Shi XB,et al.Oncomir miR-125b suppresses p14(ARF)to modulate p53-dependent and p53-independent apoptosis in prostate cancer.PLo S One,2013,8(4):e61064.
  • 9Hirata H,Ueno K,Shahryari V,et al.MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2,RECK and MTSS1 genes in human prostate cancer.PLo S One,2013,8(1):e55502.
  • 10He L,Yao H,Fan LH,et al.MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3.Genet Mol Res,2013,12(2):1012-1021.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部